Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
11/22/2012 | CA2834182A1 Honey composition with l-alanyl-l-glutamine |
11/22/2012 | CA2833515A1 High-affinity, dimeric inhibitors of psd-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain |
11/22/2012 | CA2833219A1 Medical food for cognitive decline |
11/22/2012 | CA2832384A1 1,3-oxazines as bace1 and/or bace2 inhibitors |
11/22/2012 | CA2820845A1 A water soluble composition comprising curcumin having enhanced bioavailability and process thereof |
11/21/2012 | EP2524921A1 Novel Crystalline Salts of Asenapine |
11/21/2012 | EP2524920A1 Novel Crystalline Asenapine Hydrochloride Salt Forms |
11/21/2012 | EP2524919A1 Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids |
11/21/2012 | EP2524697A1 Therapeutic agent for promoting recovery of animal under medical treatment |
11/21/2012 | EP2524694A1 Use of sigma ligands in diabetes type-2 associated pain |
11/21/2012 | EP2523958A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
11/21/2012 | EP2523955A1 Novel substituted bicyclic triazole derivatives as gamma secretase modulators |
11/21/2012 | EP2523953A1 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors |
11/21/2012 | EP2523949A1 Novel substituted triazole derivatives as gamma secretase modulators |
11/21/2012 | EP2523945A1 1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors |
11/21/2012 | EP2523674A1 Compositions comprising andrographis paniculata and gingko biloba extracts complexed with phospholipids |
11/21/2012 | EP2523668A1 Treatment of multiple sclerosis |
11/21/2012 | EP2523666A1 A pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties |
11/21/2012 | EP2523661A1 Compounds for the treatment of autism |
11/21/2012 | EP2523563A1 Method of treating neurological conditions with cardiac glycosides |
11/21/2012 | EP2523562A1 Nicotinic acetylcholine receptor modulators |
11/21/2012 | EP2523560A1 Compounds and methods |
11/21/2012 | EP2523552A1 Pyrazolo[1,5-a]pyrimidines as mark inhibitors |
11/21/2012 | CN102791863A Tctex-1 regulatory sequence region as stem cell marker |
11/21/2012 | CN102791718A Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands |
11/21/2012 | CN102791714A N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as PDE10A inhibitors |
11/21/2012 | CN102791713A Imidazo [1,2-A] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases |
11/21/2012 | CN102791704A Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
11/21/2012 | CN102791703A Pyrazines as delta opioid receptor modulators |
11/21/2012 | CN102791695A Cyclopentyl- and cycloheptylpyrazoles as FXR modulators |
11/21/2012 | CN102791688A Estrogen receptor ligands |
11/21/2012 | CN102791294A Particles for multiple agent delivery |
11/21/2012 | CN102791292A Delivery system for diagnostic and therapeutic agents |
11/21/2012 | CN102791269A PPAR-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases |
11/21/2012 | CN102791268A Treating critically ill patients with intravenous ibuprofen |
11/21/2012 | CN102787054A Wind-dispelling healthcare liquor |
11/21/2012 | CN102786525A N-substituted pyrazolo [3, 4-d] pyrimidine ketone compound and preparation method and application thereof |
11/21/2012 | CN102786521A Risperidone crystal III substance, its preparation method and its applications in medicines and healthcare products |
11/21/2012 | CN102786517A Pyrimidine thiazole amine derivative having GK (glucokinase) and PPAR (peroxidase proliferator-activated receptor) dual agonist activities |
11/21/2012 | CN102786515A 2-(2, 2-dimethyl-2, 3-dihydrobenzofuran-5-group)morpholine and preparation method and application |
11/21/2012 | CN102786483A Medicinal use of 4-(4-phenylpiperazino)quinazoline derivatives |
11/21/2012 | CN102786476A Novel compounds as opioid receptor modulators |
11/21/2012 | CN102786469A O-pyridylhydrazide derivatives, and preparation method, medicinal composition and uses thereof |
11/21/2012 | CN102786468A Nicotinic acid derivative having GK (glucokinase) and PPAR (peroxidase proliferator-activated receptor) dual agonist activities |
11/21/2012 | CN102786447A N,N-disubstituted aryl sulfonamide compound as well as preparation method and purpose of N,N-disubstituted aryl sulfonamide compound |
11/21/2012 | CN102786418A Chlorogenic acid crystal II characterization and preparation methods, and applications of chlorogenic acid crystal II in medicines and healthcare products |
11/21/2012 | CN102786417A Chlorogenic acid crystal III characterization and preparation methods, and applications of chlorogenic acid crystal III in medicines and healthcare products |
11/21/2012 | CN102786414A Compound for treating and/or preventing neurodegenerative related disease |
11/21/2012 | CN102786402A 1-(2-hydroxyl-4-isoamylene oxy)-phenyl-3-substituted phenyl-2-propylene-1-ketone derivative used for antidepressant drugs |
11/21/2012 | CN102784385A Peptide selection method |
11/21/2012 | CN102784383A Methods for preventing mitochondrial permeability transition |
11/21/2012 | CN102784373A Method for preparing traditional Chinese medicine for treating insomnia caused by malnutrition |
11/21/2012 | CN102784372A Preparation method of traditional Chinese medicine for treating spleen deficiency insomnia |
11/21/2012 | CN102784370A Traditional Chinese medicine decoction for treating deficiency-cold sciatica |
11/21/2012 | CN102784362A Externally applied medicine for treating dysphasia and preparation method thereof |
11/21/2012 | CN102784359A Medicine for treating senile dementia and preparation method of medicine |
11/21/2012 | CN102784358A Preparation method of traditional Chinese medicine for treating liver stagnation insomnia |
11/21/2012 | CN102784357A Method for preparing traditional Chinese medicine for treating insomnia caused by addiction to strong tea |
11/21/2012 | CN102784356A Method for preparing traditional Chinese medicine for treating insomnia caused by pain |
11/21/2012 | CN102784351A Jujube kernel-poria cocos-oolong teabag and manufacture method thereof |
11/21/2012 | CN102784349A Method for preparing traditional Chinese medicine for treating insomnia caused by overfeeding oily food |
11/21/2012 | CN102784347A Traditional Chinese medicine for treating headache |
11/21/2012 | CN102784346A Radix polygonati officinalis-liquorice-oolong teabag and manufacture method thereof |
11/21/2012 | CN102784326A Method for preparing traditional Chinese medicine for treating insomnia caused by dark urine |
11/21/2012 | CN102784323A Kudzuvine root-radix angelicae-oolong granule and manufacture method thereof |
11/21/2012 | CN102784319A Method for preparing traditional Chinese medicine for treating insomnia caused by deficiency of both qi and yin |
11/21/2012 | CN102784318A Preparation method of traditional Chinese medicine for treating frequent and urgent micturition insomnia |
11/21/2012 | CN102784310A Traditional Chinese medicine composition for treating headache and dizziness of apoplexy sequela |
11/21/2012 | CN102784309A Drug for treating vertigo, and preparation method thereof |
11/21/2012 | CN102784308A Chinese medicine composition for treating neurasthenia |
11/21/2012 | CN102784303A Method for preparing traditional Chinese medicine for treating insomnia caused by sweating at night |
11/21/2012 | CN102784302A Method for preparing traditional Chinese medicine for treating insomnia caused by deficiency of kidney yin |
11/21/2012 | CN102784298A Preparation method of traditional Chinese medicine for treating mustard gourmand type insomnia |
11/21/2012 | CN102784288A Traditional Chinese medicine formula for treating insomnia |
11/21/2012 | CN102784283A Jujube seed nerve soothing tablet |
11/21/2012 | CN102784280A Traditional Chinese medicine fumigating and washing liquid for treating migraine |
11/21/2012 | CN102784279A Method for preparing traditional Chinese medicine for treating insomnia caused by constipation malnutrition |
11/21/2012 | CN102784278A Method for preparing traditional Chinese medicine for treating insomnia caused by parasitic malnutrition |
11/21/2012 | CN102784273A Method for preparing traditional Chinese medicine for treating insomnia caused by high blood pressure |
11/21/2012 | CN102784257A Medicine composition for treating mild cognitive impairment |
11/21/2012 | CN102784250A Method for preparing traditional Chinese medicine for treating insomnia caused by engorgement |
11/21/2012 | CN102784236A Method for preparing traditional Chinese medicine for treating insomnia caused by anger |
11/21/2012 | CN102784214A Dropping pills for treating cerebral arteriosclerosis and cerebral hemorrhage sequela and preparation method thereof |
11/21/2012 | CN102784202A Traditional Chinese medicine for treating headache and nasal obstruction |
11/21/2012 | CN102784162A Edible fungi compound polysaccharides health care treatment preparation |
11/21/2012 | CN102784160A Application of forsythin to preparation of medicine for improving cognitive function and treating Alzheimer's diseases |
11/21/2012 | CN102784150A Clozapine cyclodextrin inclusion compound and preparation method thereof |
11/21/2012 | CN102784149A 5-aryl-9-alkyl-4,6-dioxo-1-aza-bicyclo[3.3.1]nonane and application of salt thereof |
11/21/2012 | CN102784146A Medicinal use of N-phenylquinazolinyl-4-amine derivatives |
11/21/2012 | CN102784142A Application of rapamycin in preparing medicament for treating nicotine addiction |
11/21/2012 | CN102784135A Application of equol-based BKCa channel activation |
11/21/2012 | CN102784133A Application of salvianic acid A in prevention and/or treatment of brain microvascular thromboembolic diseases |
11/21/2012 | CN102784132A Application of succinic acid and salt or ester of succinic acid in preparation of monoamine oxidase inhibitor |
11/21/2012 | CN102784131A Paeonol inclusion compound and preparation method thereof |
11/21/2012 | CN102784115A Oral tablet containing iloperidone, and its preparation method |
11/21/2012 | CN102784111A Sustained-release preparation of dopamine receptor agonist drugs |
11/21/2012 | CN102784106A Oral calcitonin liposome and lyophilized preparation thereof |
11/21/2012 | CN102784102A Tetraodotoxin oral liquid state preparation and preparation method thereof |
11/21/2012 | CN102784101A Metadoxine injection and preparation method thereof |
11/21/2012 | CN102784098A Magnesium valproate injection and preparation method thereof |